Lemnisca
Category: AI in Biotech / Drug Discovery
Lemnisca builds a science-aware AI companion that creates digital twins of fermentation processes, enabling real-time optimization, risk reduction, and faster scale-up for biomanufacturing. Lemnisca was founded in 2024. The company is led by Pushkar Pendse. Based in Bengaluru, India. Team size: 2-10. Total funding raised: Undisclosed. Latest round: Pre-seed. Key investors include Theia Ventures, PointOne Capital, Dr. Satakarni Makkapati.
- Founded
- 2024
- Headquarters
- Bengaluru, India
- Team size
- 2-10
- Total funding
- Undisclosed
Value proposition
Cuts bioprocess development timelines by up to 50%, improves yield stability by ~25%, and reduces scale-up risk, helping manufacturers adopt renewable feedstocks faster.
Products and solutions
Lemnisca Tune — fermentation readiness & model-guided optimization (lab→pilot, up to 5x faster), Lemnisca Torch — scale-up risk predictor (MOSCH report: Mixing, Oxygen, Shear, CO₂, Heat), Lemnisca Thrust — pilot→industrial scale (coming soon), Flight-simulator core: hybrid AI-ML + metabolism/reactor-physics digital twins with wet-lab loop
Unique value
Science-aware AI companion focused exclusively on fermentation, leveraging hybrid mechanistic-ML models and proprietary digital twin technology, unlike broader synthetic biology platforms.
Target customer
Contract Development and Manufacturing Organizations (CDMOs), Original Equipment Manufacturers (OEMs)/Systems Integrators (SIs), and global ingredient brands seeking sustainable bioproduction.
Industries served
Industrial biotechnology, Pharmaceuticals, Food and beverage, Enzyme production, Bio-based chemicals
Technology advantage
Hybrid mechanistic-ML models combined with real-time sensor data create high-fidelity digital twins; pending patents protect the core algorithms.
How they differentiate
Lemnisca differentiates through its science-aware AI companion specifically optimized for fermentation processes, leveraging hybrid mechanistic-ML models and proprietary digital twin technology, rather than being a broad synthetic biology platform.
Main competitors
Algocell, Synthace, DataHow, BioReact, New Wave Biotech
Key partnerships
Theia Ventures (lead investor), PointOne Capital (investor), Dr. Satakarni Makkapati (advisor), Pilot collaborations with unnamed CDMOs and OEMs
Notable customers
No publicly disclosed notable customers; pilot collaborations are ongoing with unnamed CDMOs
Major milestones
Founded 2024; Bengaluru lab / wet-lab capabilities operational (2025), Closed undisclosed pre-seed led by Theia Ventures with PointOne Capital and Dr. Satakarni Makkapati (Nov 2025), Launched Lemnisca Tune (fermentation readiness/optimization) and Lemnisca Torch (MOSCH scale-up risk scoring) (~mid-2026); Thrust coming soon, Hosted at Bangalore Bioinnovation Centre / Scaler Innovation Lab collaborations
Growth metrics
No public growth metrics disclosed as of Dec 2025
Market positioning
Positioned as a pioneer in AI-driven biomanufacturing scale-up, focusing on making bioproduction processes faster, smarter, and globally accessible through digital operating systems.
Geographic focus
Primarily focused on India (Bengaluru lab) with global industry partnerships, targeting sustainable bioproduction markets worldwide.
Patents and IP
None publicly verified; cited US20240012345A appears non-existent / placeholder (no matching public filings found for Lemnisca or Pendse on fermentation digital twins).
About Pushkar Pendse
PhD in Complex Systems Modelling (University of Maryland, College Park); chemical engineer; specializes in hybrid process models/digital twins. Former Principal Consultant & Pharma 4.0 Lead at TÜV SÜD Digital Service (Singapore); ISPE Pharma 4.0 working group; prior life-sciences digital/manufacturing consulting. CEO & Co-founder Lemnisca (from ~Jul 2025).
Latest news about Lemnisca
More AI in Biotech / Drug Discovery companies
Official website: https://www.lemnisca.bio
